ECI invests in 4Ways

Read Time: 2 Min


ECI is pleased to announce our investment in 4Ways, a leading, high growth, teleradiology company. Headquartered in Hertfordshire, 4Ways operates a 24hrs a day, tech-enabled service, providing routine, out-of-hours and specialist clinical reporting on diagnostic images which helps hospitals, CCGs and other healthcare providers to deliver high quality and efficient care to their patients. 

Over the past three years, the company has scaled rapidly, continuously improving quality and developing new service lines. Turnover has more than doubled and today the company reports almost a million scans per annum for more than 100 healthcare sites.

Ajay Chadha, CEO of 4Ways, said:

We are delighted to now be working with ECI Partners as we continue the growth and development of 4Ways Healthcare. Over the last seven years, we have built 4Ways Healthcare into a leading UK-based provider of tele-radiology services, now reporting almost a million scans per year. As we enter this next phase of growth, ECI will be able to help us better serve our clients and those patients’ whose scans we report. New infrastructure investments and resources will help our business improve its operational efficiency to meet ever increasing demand for radiology reporting services. We look forward to continued partnership working with our NHS and private clients with ECI’s support.”

Ajay Chadha 

CEO of 4Ways

George Moss, Partner at ECI commented:

Healthcare spend continues to increase substantially as the UK’s population ages and grows, while hospitals and health professionals are under pressure to deliver clinically excellent services efficiently and on budget. We are delighted to be able to partner with 4Ways, a company that is helping them to do this. ECI has a strong track record of working with growth companies and we look forward to partnering with Ajay and his team as they look to build out the business further in this very promising market.”

George Moss 

Partner at ECI

ECI announce close of latest fund

Find out more